Should You Accumulate Trxade Health Inc (MEDS) Stock Tuesday?
Tuesday, September 27, 2022 12:50 PM | InvestorsObserver Analysts
Mentioned in this article
Trxade Health Inc (MEDS) stock is lower by -78.17% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MEDS stock a score of 30 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 0. MEDS's rank also includes a long-term technical score of 6.
MEDS has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on MEDS!
Trxade Health Inc (MEDS) stock is down -0.88% while the S&P 500 is lower by -0.51% as of 12:30 PM on Tuesday, Sep 27. MEDS is lower by -$0.01 from the previous closing price of $1.13 on volume of 48,450 shares. Over the past year the S&P 500 has fallen -18.16% while MEDS is lower by -78.17%. MEDS lost -$0.51 per share in the over the last 12 months.
Click Here to get the full Stock Report for Trxade Health Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
